Skip to main content
Premium Trial:

Request an Annual Quote

In Case You Missed It, Altman Rounds Up the Past Year

At Building Confidence, Russ Altman recapitulates his translational bioinformatics "Year in Review" talk in which he highlighted three papers. The first, from Homer et al., shows that if you have a person's genotype data, you can determine if they are part of a DNA mixture. Altman adds that that's a decent "if," and he's said that "DNA anonymity is basically a fiction." He then moves on to Nyholt et al.'s paper that resolved Jim Watson's APOE status by using linkage disequilibrium correlations. Altman comments that scientists should "be careful what you release, because you may be releasing more than you think." Lastly, he points to the Christley et al. paper that showed that Watson's genome can be compressed to 4.1 Mb and emailed. "So the full circle (?) is achieved: we identify genomes, we infer things about them, and then we email them to our friends."

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.